Boston Family Office’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Boston Family Office's AGN Position: Q3 2018 in Review
Boston Family Office sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 2,025 shares — an estimated $338K sold.
Boston Family Office first reported a position in AGN in Q3 2014 and held it in 16 quarters. The position peaked at $2.28M in Q1 2016. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.
- Boston Family Office reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
- Boston Family Office sold 2,025 Allergan plc shares in Q3 2018, an estimated $338K.
- Boston Family Office first reported a position in Allergan plc in Q3 2014 and held it in 16 quarters.
- Boston Family Office's Allergan plc position peaked at $2.28M in Q1 2016.
- 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.
Based on Boston Family Office's 13F filing for Q3 2018, filed 1 Nov 2018.